Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
While direct clinical trials specifically on active acne vulgaris are limited, the observed benefits are highly relevant to acne-prone skin: Improved Skin Density and Thickness: Clinical studies have shown GHK-Cus ability to increase skin density and thickness, which can contribute to a plumper appearance and potentially reduce the visibility of shallow scars
Key distinctions in the evidence: Tesamorelin: licensed in the US, narrowly indicated, established in HIV-related lipodystrophy, with effects that reverse on stopping treatment Retatrutide: investigational, broader metabolic potential, not yet approved anywhere globally Patients and clinicians should interpret early-phase data for retatrutide with appropriate caution
If you see 10 new patients, you pay the platform fee 10 times
Regulation of cellular senescence via the FOXO4-p53 axis
BiFC is based on in vivo recombination of fluorescent proteins, and its signals are easily quantified, allowing efficient cell-based high-throughput screening
People with certain medical conditions, blood disorders, or infections, may not be suitable candidates for stem cell therapy
US$ 22.09
US$ 27.03
US$ 22.34
US$ 20.07
US$ 29.48
US$ 29.88
US$ 22.94
